Vuno Inc. (338220.KQ)
Seoul, KR
Vuno Inc. specializes in developing artificial intelligence solutions for the medical industry. The company's AI-driven offerings are designed to analyze diverse medical data, providing crucial assistance in diagnosing various diseases. Its comprehensive product suite includes BoneAge, an AI software for assessing bone age; DeepBrain, a quantitative brain parcellation tool for analyzing neurodegenerative and other neurological conditions; an AI-powered diagnostic support system for detecting abnormalities in chest X-rays; Fundus AI, an AI-based screening solution for retinal irregularities; and LungCT AI, which focuses on detecting and reporting pulmonary lung nodules. Established in 2014, the company is headquartered in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.07% | -18.31% | -52.69% | -52.91% | -66.84% | -61.91% | -48.03% | -56.35% | -59.23% | -72.10% | -72.10% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%+34.7% ★ Q1'26: -19.7% (vs Q1'25)
-
EPS growth Software - Application: +28.6%+60.6% ★ Q1'26: -21.2% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%-18.5% Q1'26: -46.1% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%-14.2% Q1'26: -67.9% (vs Q1'25)
-
ROIC Software - Application: +7.5%-39.0% Q1'26: -135.9% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+12.6% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-15.89× Q1'26: -4.01× (vs Q1'25)
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
13.28B
est: 13.30B (-0.2%)
|
25.87B
est: 26.60B (-2.7%)
|
34.85B
est: 40.90B (-14.8%)
|
59.00B
59.00B – 59.00B
+44.3% YoY
|
74.70B
74.70B – 74.70B
+26.6% YoY
|
| EBITDA |
-13.33B
est: -11.76B (-13.3%)
|
-10.91B
est: -18.70B (+41.7%)
|
-3.26B
est: -28.75B (+88.7%)
|
-41.48B
-41.48B – -41.48B
-44.3% YoY
|
-52.52B
-52.52B – -52.52B
-26.6% YoY
|
| EBIT |
-14.75B
est: -11.92B (-23.7%)
|
-12.44B
est: -19.27B (+35.5%)
|
-4.94B
est: -29.63B (+83.3%)
|
-42.74B
-42.74B – -42.74B
-44.3% YoY
|
-54.12B
-54.12B – -54.12B
-26.6% YoY
|
| Net Income |
-15.63B
est: -16.00B (+2.3%)
|
-13.02B
est: -9.14B (-42.5%)
|
-5.78B
est: -61.73M (-9,265.6%)
|
6.54B
6.54B – 6.54B
+10,700.0% YoY
|
16.02B
16.02B – 16.02B
+144.8% YoY
|
| SGA |
11.95B
est: 15.95B (-25.0%)
|
20.29B
est: 22.27B (-8.9%)
|
—
est: 34.25B (-100.0%)
|
49.40B
49.40B – 49.40B
+44.3% YoY
|
62.55B
62.55B – 62.55B
+26.6% YoY
|
| EPS |
-1,342.00
est: -1,167.00 (-15.0%)
|
-949.71
est: -592.00 (-60.4%)
|
-413.77
est: -4.00 (-10,244.3%)
|
424.00
424.00 – 424.00
+10,700.0% YoY
|
1,038.00
1,038.00 – 1,038.00
+144.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco Dow Jones Islamic Global Developed Markets UCITS ETF IGDA.L | 0.00% | 1.1K | 0.40% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ye-ha Lee | CEO & Executive Director | 725M | male |
| JunHong Kim | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 338220.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
